Cancer Clinical Trial - Celldex CDX1140-01

Cancer

Status:

Open and enrolling

ClinicalTrials.gov:

NCT03329950

Celldex CDX1140-01 - A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies CONDITION(S): Pancreatic cancer

Drug

CDX-1140 + gemcitabine + nab-paclitaxel

Trial Type

Treatment

Condition

Pancreatic cancer

Keywords

Celldex | Pancreatic cancer